John P. Hamill - Net Worth and Insider Trading
John P. Hamill Net Worth
The estimated net worth of John P. Hamill is at least $91,672 dollars as of 2024-05-16. John P. Hamill is the SrVP/CFO/Prin Fin & Acct Ofcr of Aprea Therapeutics Inc and owns about 15,503 shares of Aprea Therapeutics Inc (APRE) stock worth over $89,917. John P. Hamill is the VP Fin,Princ Fin&Acct Officer of Trevena Inc and owns about 3,289 shares of Trevena Inc (TRVN) stock worth over $1,382. John P. Hamill is also the SVP & CFO of Windtree Therapeutics Inc and owns about 81 shares of Windtree Therapeutics Inc (WINT) stock worth over $373. Details can be seen in John P. Hamill's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that John P. Hamill has not made any transactions after 2024-03-13 and currently still holds the listed stock(s).
Transaction Summary of John P. Hamill
John P. Hamill Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, John P. Hamill owns 4 companies in total, including Windtree Therapeutics Inc (WINT) , Trevena Inc (TRVN) , and Cellectar Biosciences Inc (CLRB) among others .
Click here to see the complete history of John P. Hamill’s form 4 insider trades.
Insider Ownership Summary of John P. Hamill
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| WINT | Windtree Therapeutics Inc | 2022-07-26 | SVP & CFO |
| TRVN | Trevena Inc | 2019-05-31 | Int. Prin. Fin. Off. and PAO |
| CLRB | Cellectar Biosciences Inc | 2017-09-05 | Interim CFO |
 | | 2024-03-13 | SrVP/CFO/Prin. Fin &Acctg. Off |
John P. Hamill Latest Holdings Summary
John P. Hamill currently owns a total of 3 stocks. Among these stocks, John P. Hamill owns 15,503 shares of Aprea Therapeutics Inc (APRE) as of March 13, 2024, with a value of $89,917 and a weighting of 98.09%. John P. Hamill owns 3,289 shares of Trevena Inc (TRVN) as of May 31, 2019, with a value of $1,382 and a weighting of 1.51%. John P. Hamill also owns 81 shares of Windtree Therapeutics Inc (WINT) as of July 26, 2022, with a value of $373 and a weighting of 0.41%.
Latest Holdings of John P. Hamill
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| APRE | Aprea Therapeutics Inc | 2024-03-13 | 15,503 | 5.80 | 89,917 |
| TRVN | Trevena Inc | 2019-05-31 | 3,289 | 0.42 | 1,382 |
| WINT | Windtree Therapeutics Inc | 2022-07-26 | 81 | 4.60 | 373 |
Holding Weightings of John P. Hamill
John P. Hamill Form 4 Trading Tracker
According to the SEC Form 4 filings, John P. Hamill has made a total of 1 transactions in Aprea Therapeutics Inc (APRE) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Aprea Therapeutics Inc is the acquisition of 1,010 shares on March 13, 2024, which cost John P. Hamill around $7,363.
According to the SEC Form 4 filings, John P. Hamill has made a total of 1 transactions in Trevena Inc (TRVN) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Trevena Inc is the acquisition of 300 shares on May 31, 2019, which cost John P. Hamill around $8,700.
According to the SEC Form 4 filings, John P. Hamill has made a total of 4 transactions in Windtree Therapeutics Inc (WINT) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in Windtree Therapeutics Inc is the acquisition of 3 shares on July 26, 2022, which cost John P. Hamill around $1,110.
Insider Trading History of John P. Hamill
- 1
John P. Hamill Trading Performance
GuruFocus tracks the stock performance after each of John P. Hamill's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John P. Hamill is -17.57%. GuruFocus also compares John P. Hamill's trading performance to market benchmark return within the same time period. The performance of stocks bought by John P. Hamill within 3 months outperforms 0 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how John P. Hamill's insider trading performs compared to the benchmark.
Performance of John P. Hamill
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 2.75 | | | | | |
| Relative Return to S&P 500(%) | -0.53 | | | | | |
John P. Hamill Ownership Network
John P. Hamill Owned Company Details
What does Windtree Therapeutics Inc do?
Who are the key executives at Windtree Therapeutics Inc?
John P. Hamill is the SVP & CFO of Windtree Therapeutics Inc. Other key executives at Windtree Therapeutics Inc include director & Chief Executive Officer Craig Fraser , VP & Controller & & CAO Jamie Mcandrew , and 10 percent owner Center Laboratories, Inc. .
Windtree Therapeutics Inc (WINT) Insider Trades Summary
Over the past 18 months, John P. Hamill made no insider transaction in Windtree Therapeutics Inc (WINT). Other recent insider transactions involving Windtree Therapeutics Inc (WINT) include a net purchase of 7,812 shares made by Craig Fraser ,
In summary, during the past 3 months, insiders sold 0 shares of Windtree Therapeutics Inc (WINT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Windtree Therapeutics Inc (WINT) were sold and 434 shares were bought by its insiders, resulting in a net purchase of 434 shares.
Windtree Therapeutics Inc (WINT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Windtree Therapeutics Inc Insider Transactions
John P. Hamill Mailing Address
Above is the net worth, insider trading, and ownership report for John P. Hamill. You might contact John P. Hamill via mailing address: 4092 New Hope Road, Furlong Pa 18925.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
